Xavier Nadal
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effect of temperature in the degradation of cannabinoids: From a brief residence in the gas chromatography inlet port to a longer period in thermal treatments.
Journal: Frontiers in chemistry
Published: September 07, 2022
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors.
Journal: Pharmacological research
Published: October 07, 2021
A Comparative In Vitro Study of the Neuroprotective Effect Induced by Cannabidiol, Cannabigerol, and Their Respective Acid Forms: Relevance of the 5-HT1A Receptors.
Journal: Neurotoxicity research
Published: June 10, 2020
Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors.
Journal: Pharmacological research
Published: April 19, 2020
Cannabidiol Prevents the Expression of the Locomotor Sensitization and the Metabolic Changes in the Nucleus Accumbens and Prefrontal Cortex Elicited by the Combined Administration of Cocaine and Caffeine in Rats.
Journal: Neurotoxicity research
Published: March 19, 2020
Pharmacological potential of varinic-, minor-, and acidic phytocannabinoids.
Journal: Pharmacological research
Published: February 05, 2020
Tetrahydrocannabinolic acid A (THCA-A) reduces adiposity and prevents metabolic disease caused by diet-induced obesity.
Journal: Biochemical pharmacology
Published: September 29, 2019
Cannabidiol skews biased agonism at cannabinoid CB1 and CB2 receptors with smaller effect in CB1-CB2 heteroreceptor complexes.
Journal: Biochemical pharmacology
Published: May 31, 2018
Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes.
Journal: Frontiers in pharmacology
Published: February 22, 2018
Binding and Signaling Studies Disclose a Potential Allosteric Site for Cannabidiol in Cannabinoid CB2 Receptors.
Journal: Frontiers in pharmacology
Published: June 29, 2017
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.
Journal: British journal of pharmacology
Published: March 28, 2017
Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.
Journal: Pharmacology research & perspectives
Published: September 12, 2014
Last Updated: 09/26/2026